Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

about

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

Item

http://www.wikidata.org/entity/Q57490969

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 27 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@en

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@nl

type

Item

label

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@en

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@nl

prefLabel

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@en

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@nl

P1476

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

@en

P2093

Anke-Hilse Maitland-van der Zee

http://www.w3.org/2001/XMLSchema#string

Geoffrey Liu

http://www.w3.org/2001/XMLSchema#string

Joris Veltman

http://www.w3.org/2001/XMLSchema#string

Paul Baas

http://www.w3.org/2001/XMLSchema#string

Susanne Vijverberg

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis

Mechanisms of Cisplatin nephrotoxicity

Acute nephrotoxicity of cisplatin: molecular mechanisms

Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells

ERCC2/XPD gene polymorphisms and cancer risk

A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis

Membrane transporters as mediators of Cisplatin effects and side effects.

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

P304

1111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01111

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319427

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6171472

http://www.w3.org/2001/XMLSchema#string